Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anna Garratt"'
Autor:
Kate Nash, Anna Garratt
Publikováno v:
British Journal of Midwifery. 29:546-548
Kate Nash and Anna Garratt discuss how quality improvement can make an impact on practice and summarise the key approaches to this process
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e50e7774ecd5174ee210d09b13ec51d5
https://doi.org/10.12968/bjom.2021.29.10.546
https://doi.org/10.12968/bjom.2021.29.10.546
Autor:
Anna Garratt, Jacob Levi, Amir H. Davarpanah, Hannah Wentzel, Zahedin Kheiri, Ali Ali Asgari, Shirin Afhami, Andrew Hill, Amir Anushirvani, Ambar Qavi, Anahita Sadeghi, Hadiseh Hosamirudsai, Rasoul Aliannejad, Bryony Simmons, Shahin Merat, Mahnaz Montazeri, Elham Akbarpour, Alireza Norouzi, Amir Reza Radmard
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background Currently no effective antiviral therapy has been found to treat COVID-19. The aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical outcomes in patients with moderate or severe COVID-19. Methods T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5e5e65393785b51570902cb135294dd
https://doi.org/10.1093/jac/dkaa334
https://doi.org/10.1093/jac/dkaa334
BACKGROUND: Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b880963ff2b5f505b3e7a43c4f590b20
http://hdl.handle.net/10044/1/96752
http://hdl.handle.net/10044/1/96752
Autor:
Kaitlyn McCann, Jonathan Falconer, Anna Garratt, Jacob Levi, Hannah Wentzel, Junzheng Wang, Victoria Pilkington, Andrew Hill, Ambar Qavi, Leah Ellis
Publikováno v:
Open Forum Infectious Diseases. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c92cc3a113bdbb16abf633c1d172c8f
https://doi.org/10.1093/ofid/ofab394
https://doi.org/10.1093/ofid/ofab394
Autor:
Jonathan Falconer, Hannah Wentzel, Victoria Pilkington, Andrew Hill, Ambar Qavi, Jacob Levi, Kaitlyn McCann, Anna Garratt, Junzheng Wang, Leah Ellis
Publikováno v:
Open Forum Infectious Diseases. 8
Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity against SARS-COV-2, but only at high concentrations. This meta-analysis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::577e86448bcdde3bd1b3260afde221be
https://doi.org/10.1093/ofid/ofab358
https://doi.org/10.1093/ofid/ofab358
Autor:
Andrew, Hill, Anna, Garratt, Jacob, Levi, Jonathan, Falconer, Leah, Ellis, Kaitlyn, McCann, Victoria, Pilkington, Ambar, Qavi, Junzheng, Wang, Hannah, Wentzel
Publikováno v:
Open Forum Infectious Diseases
Ivermectin is an antiparasitic drug being investigated for repurposing against SARS-CoV-2. Ivermectin showed in-vitro activity against SARS-COV-2 at high concentrations. This meta-analysis investigated ivermectin in 24 randomized clinical trials (332
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::06237c7f0e926bf95e568623163f300e
http://europepmc.org/articles/PMC8420640
http://europepmc.org/articles/PMC8420640
Autor:
Nikolien S van De Ven, Lynne M. Mofenson, Anton L Pozniak, Andrew Hill, Jacob A Levi, Polly Clayden, Anna Garratt, Christopher Redd
Publikováno v:
Clinical Infectious Diseases. 70:2599-2606
BackgroundThe Botswana Tsepamo study reported neural tube defects (NTDs) in 4 of 426 (0.94%) infants of women receiving preconception dolutegravir (DTG) antiretroviral therapy (ART) vs 14 of 11 300 (0.12%) receiving preconception non-DTG ART. Data ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b83e5250c1626899cbd5511aae7f0d1
https://doi.org/10.1093/cid/ciz684
https://doi.org/10.1093/cid/ciz684
Autor:
Andrew Hill, Ahmed Abdulamir, Sabeena Ahmed, Asma Asghar, Olufemi Emmanuel Babalola, Rabia Basri, Carlos Chaccour, Aijaz Zeeshan Khan Chachar, Abu Tauib Mohammed Chowdhury, Ahmed Elgazzar, Leah Ellis, Jonathan Falconer, Anna Garratt, Basma Hany, Hashim A Hashim, Wasim Ul Haque, Arshad Hayat, Shuixiang He, Ramin Jamshidian, Wasif Ali Khan, Ravi Kirti, Alejandro Krolewiecki, Carlos Lanusse, Jacob Levi, Reaz Mahmud, Sermand Ahmed Mangat, Kaitlyn McCann, Anant Mohan, Mortezza Shakshi Niaee, Nurullah Okumus, Victoria Pilkington, Chinmay Saha Podder, Ambar Qavi, Houssam Raad, Mohammaed Sadegh Rezai, Surapaneni Sasank, Veerapaneni Spoorthi, Tejas Suri, Junzheng Wang, Hannah Wentzel
Ivermectin is an antiparasitic drug being investigated for repurposing to SARS-CoV-2. In-vitro, ivermectin showed limited antiviral activity and a COVID-19 animal model demonstrated pathological benefits but no effect on viral RNA. This meta-analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efcc6d80423cf6cc9688126d8d0c8e7b
https://doi.org/10.21203/rs.3.rs-148845/v1
https://doi.org/10.21203/rs.3.rs-148845/v1
Autor:
Linda Tyson, Catherine Moore, Nicki Palmer, Lisa Chichester, Owen Vineall, Isa Murrell, Donall Forde, Anna Garratt, Rachel Jones
There is a requirement for easily accessible, high throughput serological testing as part of the SARS-CoV-2 pandemic response. Whilst of limited diagnostic use in an acute individual setting, its use on a population level is key to informing a cohere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da6e6ddca5ce31f3d6c1685e4083606f
https://doi.org/10.1101/2020.10.29.20219931
https://doi.org/10.1101/2020.10.29.20219931